Page last updated: 2024-08-17

quinidine and 4-o-methyl-12-o-tetradecanoylphorbol 13-acetate

quinidine has been researched along with 4-o-methyl-12-o-tetradecanoylphorbol 13-acetate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berkovic, SF; Dibbens, LM; Dlugos, DJ; Gazina, EV; Goldstein, DB; Heron, SE; Li, M; Milligan, CJ; Nair, U; Petrou, S; Petrovski, S; Reid, CA; Scheffer, IE; Trager, C; Venkat, A; Younkin, DP1

Other Studies

1 other study(ies) available for quinidine and 4-o-methyl-12-o-tetradecanoylphorbol 13-acetate

ArticleYear
KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine.
    Annals of neurology, 2014, Volume: 75, Issue:4

    Topics: Animals; Brain; Dose-Response Relationship, Drug; Electric Stimulation; Humans; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Microinjections; Mutation; Nerve Tissue Proteins; Oocytes; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Sodium-Activated; Quinidine; Tetradecanoylphorbol Acetate; Time Factors; Voltage-Gated Sodium Channel Blockers; Xenopus laevis

2014